Ran Nussbaum - Insider Trading & Ownership

Location
C/O Kite Pharma, Inc., 2225 Colorado Avenue, Santa Monica, CA
Summary
The estimated net worth of Ran Nussbaum is at least $29M dollars as of September 16, 2025. Ran Nussbaum is the Director of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $26.7M. Ran Nussbaum is the Director, 10%+ Owner of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $2.24M.
Signature
/s/ Marc Panoff, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Ran Nussbaum

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
URGN UroGen Pharma Ltd. Director $26.7M Oct 21, 2022
KROS Keros Therapeutics, Inc. Director, 10%+ Owner $2.24M Jun 4, 2025
ELOX Eloxx Pharmaceuticals, Inc. Director Jun 15, 2022
LBRX LB PHARMACEUTICALS INC Director Sep 12, 2025

Insider Transactions Reported by Ran Nussbaum:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.